Marcus & Millichap, Inc. (MMI) Analysts See $0.42 EPS

February 24, 2018 - By Nellie Frank

 Marcus & Millichap, Inc. (MMI) Analysts See $0.42 EPS
Investors sentiment increased to 2.1 in Q3 2017. Its up 0.82, from 1.28 in 2017Q2. It improved, as 7 investors sold Marcus & Millichap, Inc. shares while 23 reduced holdings. 25 funds opened positions while 38 raised stakes. 13.37 million shares or 12.48% less from 15.28 million shares in 2017Q2 were reported.
Malaga Cove Capital Ltd Liability Com reported 0.34% in Marcus & Millichap, Inc. (NYSE:MMI). Clark Estates Ny, a New York-based fund reported 129,000 shares. Goldman Sachs Group invested 0% in Marcus & Millichap, Inc. (NYSE:MMI). Bancshares Of America Corp De reported 1,616 shares or 0% of all its holdings. Northern Tru holds 0% of its portfolio in Marcus & Millichap, Inc. (NYSE:MMI) for 238,777 shares. Ubs Asset Mgmt Americas accumulated 0% or 8,000 shares. Pacific Ridge Cap Partners Ltd Liability reported 57,640 shares. Tiaa Cref Invest Mgmt Lc, a New York-based fund reported 51,026 shares. 91,429 are held by Wells Fargo And Company Mn. Ameritas holds 0% in Marcus & Millichap, Inc. (NYSE:MMI) or 1,407 shares. Sprott reported 110,000 shares. Credit Suisse Ag reported 0% stake. 1.31 million were reported by Vanguard Gp. Bnp Paribas Arbitrage Sa has invested 0% in Marcus & Millichap, Inc. (NYSE:MMI). Hbk L P holds 0% in Marcus & Millichap, Inc. (NYSE:MMI) or 12,226 shares.

Analysts expect Marcus & Millichap, Inc. (NYSE:MMI) to report $0.42 EPS on March, 8.They anticipate $0.02 EPS change or 4.55 % from last quarter’s $0.44 EPS. MMI’s profit would be $16.02 million giving it 18.99 P/E if the $0.42 EPS is correct. After having $0.39 EPS previously, Marcus & Millichap, Inc.’s analysts see 7.69 % EPS growth. The stock increased 1.92% or $0.6 during the last trading session, reaching $31.9. About 107,370 shares traded. Marcus & Millichap, Inc. (NYSE:MMI) has declined 0.91% since February 24, 2017 and is downtrending. It has underperformed by 17.61% the S&P500.

Marcus & Millichap, Inc. (NYSE:MMI) Ratings Coverage

Among 4 analysts covering Marcus & Millichap (NYSE:MMI), 2 have Buy rating, 0 Sell and 2 Hold. Therefore 50% are positive. Marcus & Millichap had 11 analyst reports since August 7, 2015 according to SRatingsIntel. The firm has “Market Outperform” rating given on Wednesday, January 24 by JMP Securities. Wells Fargo maintained it with “Hold” rating and $31.0 target in Wednesday, November 8 report. The company was initiated on Tuesday, December 20 by Citigroup. The stock has “Sell” rating by Goldman Sachs on Wednesday, August 12. Goldman Sachs upgraded Marcus & Millichap, Inc. (NYSE:MMI) on Tuesday, November 10 to “Neutral” rating. As per Friday, October 23, the company rating was initiated by Wells Fargo. The stock of Marcus & Millichap, Inc. (NYSE:MMI) earned “Buy” rating by Citigroup on Tuesday, November 14. The stock has “Market Perform” rating by JMP Securities on Monday, October 26. The rating was maintained by Citigroup on Friday, August 7 with “Buy”.

Marcus & Millichap, Inc., a brokerage company, provides investment brokerage and financing services to sellers and buyers of various commercial real estate assets in the United States and Canada. The company has market cap of $1.22 billion. The firm offers commercial real estate investment sales, financing, research, and advisory services for multifamily, retail, office, and industrial properties, as well as hospitality, self-storage, seniors housing, land, and manufactured housing properties. It has a 20.71 P/E ratio. It also operates as a broker of debt financing for commercial properties.

Another recent and important Marcus & Millichap, Inc. (NYSE:MMI) news was published by Businesswire.com which published an article titled: “Marcus & Millichap, Inc. Reports Results for Third Quarter 2017” on November 07, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter: